Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On 13 February, OCTO Trial Manager Lucy Griffiths staffed a stand about Clinical Trials at a tri-school Careers Fair in West London.

The event was visited by over 1000 Secondary School and 6th Form students, plus their parents.

This was a great opportunity to highlight how we ask fair questions in clinical trials and to highlight the skills and backgrounds of the people who make up the OCTO team. 

Lucy spoke in depth to 32 students that evening helping them to understand the trials process better and the potential career options.

Some of the students hadn’t come across trials before and they were very interested to hear about both the process and the clinical trial lab based related work.  There were a few budding Doctors who were interested to know that there can be a research element to this role too.

The event had hugely positive feedback.  We're thankful that Lucy had the time to attend the careers fair - it’s so important that students understand the widest range of careers available and the skill sets that are involved in our work.

Similar stories

Festive Science Image Competition Winners

Winners of the Medical Research Foundation's second Festive Science Image Competition, run in partnership with the Medical Research Council (MRC), have been announced today.

The Howat Foundation to fund Chair in Clinical Oncology

Oxford Cancer announce the endowment of a Chair in Clinical Oncology, thanks to generous philanthropic support from The Howat Foundation

Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment

New research from the Fairfax Group has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.

MP Anneliese Dodds tours Oxford cancer research

Anneliese Dodds, MP for Oxford East & Chair of the Labour Party, visited the University of Oxford to learn more about the impactful work happening across departments in the field of cancer research.